Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis
暂无分享,去创建一个
AJ Thompson | O Ciccarelli | M. Battaglini | O. Ciccarelli | D. Miller | D. Chard | B. Bodini | R. Samson | L. Fisniku | D. Chard | RS Samson | C. Dalton | CM Dalton | A. Thompson | CM Dalton | B Bodini | RS Samson | M Battaglini | LK Fisniku | DH Miller | DT Chard | R. Samson | Andrew J. Thompson | Donald Miller
[1] A Achiron,et al. Cognitive impairment in probable multiple sclerosis , 2003, Journal of neurology, neurosurgery, and psychiatry.
[2] H. Moser,et al. Magnetic resonance imaging detection of lesion progression in adult patients with X-linked adrenoleukodystrophy. , 2007, Archives of neurology.
[3] D. Silberberg,et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.
[4] M. Battaglini,et al. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. , 2008, Archives of neurology.
[5] C. Polman,et al. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. , 2004, Archives of neurology.
[6] S. Reingold,et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.
[7] Frederik Barkhof,et al. Patterns of Brain Magnetic Resonance Abnormalities on T2-Weighted Spin Echo Images in Clinical Subgroups of Multiple Sclerosis: A Large Cross-Sectional Study , 1998, European Neurology.
[8] I. Moseley,et al. Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination , 1998, Journal of neurology, neurosurgery, and psychiatry.
[9] B. Mädler,et al. Is diffusion anisotropy an accurate monitor of myelination? Correlation of multicomponent T2 relaxation and diffusion tensor anisotropy in human brain. , 2008, Magnetic resonance imaging.
[10] A. Thompson,et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. , 2008, Brain : a journal of neurology.
[11] F. Barkhof,et al. Genetic Correlations of Brain Lesion Distribution in Multiple Sclerosis: An Exploratory Study , 2011, American Journal of Neuroradiology.
[12] Thomas E. Nichols,et al. Nonparametric permutation tests for functional neuroimaging: A primer with examples , 2002, Human brain mapping.
[13] D.L. Plummer,et al. DispImage: Un mezzo di analisi e presentazione per iconografia medica , 1992 .
[14] A. Janssens,et al. Callosal lesion predicts future attacks after clinically isolated syndrome , 2009, Neurology.
[15] C. Svarer,et al. Correlations of brain MRI parameters to disability in multiple sclerosis , 2001, Acta neurologica Scandinavica.
[16] P M Matthews,et al. Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis. , 2000, Archives of neurology.
[17] J. Bodensteiner,et al. Serial MRI and CT findings in infantile Krabbe disease. , 1992, Pediatric neurology.
[18] K. J. Kim,et al. MR of childhood metachromatic leukodystrophy. , 1997, AJNR. American journal of neuroradiology.
[19] A. Achiron,et al. Walking while talking--difficulties incurred during the initial stages of multiple sclerosis disease process. , 2010, Gait & posture.
[20] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[21] F. Barkhof,et al. Clinical correlations of brain lesion distribution in multiple sclerosis , 2009, Journal of magnetic resonance imaging : JMRI.
[22] P. Szeszko,et al. MRI atlas of human white matter , 2006 .
[23] M. Filippi,et al. A 3‐year magnetic resonance imaging study of cortical lesions in relapse‐onset multiple sclerosis , 2009, Annals of neurology.
[24] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[25] Lublin Fd,et al. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. , 1996 .
[26] M. Battaglini,et al. T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.